We are live on
!
Find out more
T
Tahithromos Portfolio holdings
AUM
$71.9M
1-Year Est. Return
0.24%
This Fund
S&P 500
This Quarter
Est. Return
-8.11%
1 Year Est. Return
-0.24%
3 Year Est. Return
+16.44%
5 Year Est. Return
+53.61%
10 Year Est. Return
–
AUM
$107M
AUM Growth
+$34.7M
(+48%)
Cap. Flow
+$172M
Cap. Flow
% of AUM
160.3%
Top 10 Holdings %
Top 10 Hldgs %
93.21%
Holding
20
New
6
Increased
7
Reduced
2
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$31.4M |
| 2 |
Radware
RDWR
|
+$7.95M |
| 3 |
Webster Financial
WBS
|
+$6.13M |
| 4 |
CF Industries
CF
|
+$2.54M |
| 5 |
HDFC Bank
HDB
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
H&R Block
HRB
|
+$5.08M |
| 2 |
DHT Holdings
DHT
|
+$3.67M |
| 3 |
Cognizant
CTSH
|
+$1.99M |
| 4 |
SZYM
SOLAZYME INC COM STK (DE)
SZYM
|
+$870K |
| 5 |
Archrock
AROC
|
+$784K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.98% |
| 2 | Healthcare | 11.19% |
| 3 | Technology | 9.92% |
| 4 | Consumer Discretionary | 6.75% |
| 5 | Consumer Staples | 3.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR Gold Trust
GLD
$133B
| $31.2M | 29% |
+291,700
| New | +$31.4M |
|
|
VER
2
DELISTED
VEREIT, Inc.
VER
| $20.6M | 19.2% |
534,651
+29,033
| +6% | +$1.21M |
|
|
3
Radware
RDWR
$1.05B
| $9.36M | 8.7% |
575,330
+417,165
| +264% | +$7.95M |
|
|
4
HDFC Bank
HDB
$124B
| $9.16M | 8.53% |
600,000
+120,000
| +25% | +$1.81M |
|
|
VVUS
5
DELISTED
Vivus Inc
VVUS
| $7.72M | 7.18% |
470,543
+73,645
| +19% | +$1.17M |
|
|
6
H&R Block
HRB
$5.61B
| $7.25M | 6.75% |
200,334
-150,040
| -43% | -$5.08M |
|
|
7
Webster Financial
WBS
$12.5B
| $5.86M | 5.46% |
+164,568
| New | +$6.13M |
|
|
MJN
8
DELISTED
Mead Johnson Nutrition Company
MJN
| $3.87M | 3.6% |
55,000
| – | – |
|
9
Dr. Reddy's Laboratories
RDY
$9.85B
| $3.2M | 2.97% |
250,000
| – | – |
|
|
10
CF Industries
CF
$19.3B
| $1.96M | 1.83% |
+43,700
| New | +$2.54M |
|
|
11
Archrock
AROC
$6.21B
| $1.63M | 1.51% |
90,293
-32,747
| -27% | -$784K |
|
12
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $1.43M | 1.33% |
402,500
+398,501
| +9,965% | +$80.8M |
|
13
Cisco
CSCO
$448B
| $1.31M | 1.22% |
+50,000
| New | +$1.35M |
|
14
Community Health Systems
CYH
$391M
| $1.11M | 1.03% |
+31,460
| New | +$1.44M |
|
15
PUT
iShares Russell 2000 ETF
IWM
$80.2B
| $957K | 0.89% |
216,000
+209,744
| +3,353% | +$24.9M |
|
16
PUT
Invesco QQQ Trust
QQQ
$450B
| $600K | 0.56% |
222,900
+220,305
| +8,490% | +$23.7M |
|
|
EPIQ
17
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $258K | 0.24% |
+20,000
| New | +$290K |
|
|
18
Cognizant
CTSH
$24.3B
| – | – |
-32,500
| Closed | -$1.99M |
|
|
19
DHT Holdings
DHT
$2.99B
| – | – |
-472,528
| Closed | -$3.67M |
|
|
SZYM
20
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| – | – |
-277,079
| Closed | -$870K |
|
Similar funds
GC
DCM
XS
SCM
BSCP
FMA
MSTVIM
LA
Tahithromos's Q3 2015 Portfolio in Review
As of Q3 2015, Tahithromos held 20 positions worth $107M, up 48% from $72.8M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Tahithromos deployed $172M of net new capital in Q3 2015, opening 6 new positions and adding to 7 existing holdings. Its largest new stake was SPDR Gold Trust: 291,700 shares worth $31.2M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 10% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was H&R Block, an estimated $5.08M trimmed.
- Tahithromos's largest Q3 2015 buy was SPDR Gold Trust: 291,700 shares worth $31.2M.
- Tahithromos added most to Radware in Q3 2015, an estimated $7.95M increase.
- Tahithromos's biggest Q3 2015 reduction was H&R Block, cutting an estimated $5.08M.
- Tahithromos fully exited DHT Holdings in Q3 2015, selling an estimated $3.67M.
- Tahithromos's ten largest holdings make up 93% of its $107M portfolio in Q3 2015.
- Tahithromos opened 6 new positions and closed 3 in Q3 2015.
- Tahithromos's portfolio value rose 48% quarter-over-quarter to $107M.
Based on Tahithromos's 13F filing for Q3 2015, filed 28 Oct 2015.